Today: 11 March 2026
Subscribe
Browse Category

Stock Market 5 February 2026

Bloom Energy stock slides in after-hours as traders brace for Thursday earnings

Bloom Energy stock slides in after-hours as traders brace for Thursday earnings

Bloom Energy shares dropped 12.8% to $147.35 in after-hours trading Wednesday after a volatile session. Wall Street expects fourth-quarter profits to fall from last year despite higher revenue, with analysts forecasting $0.25 per share on $649.12 million in sales. Investors are focused on guidance and orders tied to data-center power demand. Bloom reports earnings Thursday after the close.
5 February 2026
···
IBM stock slides again as AI disruption fears grip software; Confluent vote nears

IBM stock slides again as AI disruption fears grip software; Confluent vote nears

IBM shares fell 1.8% to $289.05 Wednesday, extending an 8% slide since Monday amid a global software selloff tied to AI disruption fears. Confluent, which IBM plans to acquire, disclosed lawsuits and shareholder demands over its merger proxy, but said it will issue supplemental disclosures. IBM declared a $1.68 per share dividend, payable March 10. Confluent shareholders will vote on the deal February 12.
5 February 2026
···
Enphase stock jumps nearly 39% — here’s what traders are watching after ENPH outlook and upgrades

Enphase stock jumps nearly 39% — here’s what traders are watching after ENPH outlook and upgrades

Enphase Energy shares soared 38.6% to $51.67 in after-hours trading Tuesday after the company projected first-quarter revenue of $270 million to $300 million. RBC and BMO raised their ratings, citing improved demand visibility. Fourth-quarter revenue reached $343.3 million, with U.S. demand up 21% but European revenue down 29%. CEO Badri Kothandaraman said bookings are about 90% filled at the midpoint of guidance.
5 February 2026
··
Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck shares rose 2.2% to $118.33 in after-hours trading Wednesday after new data showed its experimental cholesterol drug enlicitide cut LDL by up to 60% in a major trial. The company’s 2026 revenue forecast of $65.5–$67.0 billion missed Wall Street estimates, citing pressure from off-patent drugs and U.S. pricing. Keytruda sales reached $8.37 billion last quarter, while Gardasil revenue fell 34%.
5 February 2026
···
Booking (BKNG) stock slips after-hours as AI worries hit analyst notes ahead of Feb. 18 results

Booking (BKNG) stock slips after-hours as AI worries hit analyst notes ahead of Feb. 18 results

Booking Holdings shares fell 0.8% to $4,607.13 in after-hours trading Wednesday after Citizens Bank downgraded the stock, citing AI risks and a lack of near-term growth drivers. The stock has dropped 9.3% since Tuesday amid heavy volume and sector-wide declines. Booking will report fourth-quarter and full-year earnings on Feb. 18. KeyBanc maintained an overweight rating but trimmed its price target.
5 February 2026
··
Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase shares fell 6.2% to $168.62 in after-hours trading Wednesday after Nevada’s gaming regulator filed a civil enforcement action to block the company’s sports-linked event contracts. The Nevada Gaming Control Board seeks a court order halting what it calls unlicensed wagering. Coinbase called the move a “state power grab,” arguing federal law should apply. Bitcoin and ether also dropped, weighing on exchange stocks.
5 February 2026
···
Snowflake stock drops again: insider sale filing and AI jitters pressure SNOW shares

Snowflake stock drops again: insider sale filing and AI jitters pressure SNOW shares

Snowflake shares fell 4.6% to $165.29 Wednesday, extending a 13% slide since Monday. Product EVP Christian Kleinerman sold 10,000 shares at $197.09 each, a filing showed. The company closed its acquisition of Observe and announced new AI tools at its Build London event. Investors await Feb. 25 earnings for signs of demand and AI adoption.
5 February 2026
···
S&P Global stock tries to find a floor after AI scare rout; Mobility Global spin-off and earnings loom

S&P Global stock tries to find a floor after AI scare rout; Mobility Global spin-off and earnings loom

S&P Global shares fell 0.6% to $465.51 Wednesday, extending a two-day drop to nearly 12% amid concerns over AI’s impact on data firms. Trading volume was four times the 20-day average. The company’s Mobility division will rebrand as Mobility Global ahead of a planned spin-off, pending board approval. S&P Global reports earnings Feb. 10.
5 February 2026
···
Cisco stock falls after hours as tech selloff bites; CSCO earnings loom next week

Cisco stock falls after hours as tech selloff bites; CSCO earnings loom next week

Cisco shares fell 2.3% to $81.16 in after-hours trading Wednesday, following a broader tech sell-off that pushed the Nasdaq down 1.51%. The company will report fiscal Q2 earnings on Feb. 11 and recently announced NBC Sports will use its AI networking tech for the 2026 Winter Olympics. Cisco also launched an AI-powered security tool and promoted its AI strategy at a summit with Nvidia.
5 February 2026
··
AbbVie stock slides after earnings: Rinvoq miss dents ABBV despite upbeat 2026 view

AbbVie stock slides after earnings: Rinvoq miss dents ABBV despite upbeat 2026 view

AbbVie shares fell 3.9% in after-hours trading Wednesday after quarterly results showed Rinvoq sales missed expectations at $2.37 billion. Skyrizi sales beat forecasts at $5.01 billion, while Humira revenue dropped 25.9% to $1.25 billion. The company projected 2026 adjusted earnings above estimates, but investors focused on challenges replacing Humira as biosimilar competition grows.
5 February 2026
···
1 … 184 185 186 187 188 … 1,343
Go toTop